Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Clinical trial NCT04817618 · RECRUITING
Trial details
- NCT number
- NCT04817618
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2027-01-29
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.